Trialscope Disclose l Pharma Intelligence

TrialScope Disclose keeps you ahead of changing regulations and evolving expectations, empowering you to maintain global disclosure compliance from a single, centralized platform

How it helps

Everyone benefits from better transparency around clinical trials. But in a complex and ever-evolving regulatory landscape, navigating the clinical trial disclosure process can be difficult for even the most diligent sponsors. With TrialScope Disclose you can:

Simplify and centralize disclosure compliance operations globally
Automate data entry and streamline processes to reduce manual effort and submit trial information quicker and more accurately
Mitigate regulatory risk, avoid penalties, build public trust, and enjoy peace of mind
Easily track where you’re compliant, where you’re falling short and why — across your entire clinical trial portfolio
Reuse your approved trial data across different forms and global registries

How it works

TrialScope Disclose is powered by an intelligent disclosure rules engine that uses automation to keep you compliant across registries, even as regulations evolve. TrialScope Disclose will automatically:

Validate your data against field-level registry requirements
Evaluate your trials to determine what must be disclosed, on which registry, and by what date.
Alert you of impending deadlines, and can be modified to match internal policies/business rules

Professional Disclosure Services

We’re here to help your organization master the complexities of disclosure any way we can — including doing the work for you. Our team of experts can act as an extension of your team, and take your most time-consuming, cumbersome disclosure activities off your plate — from protocol registration through results posting — so you’re free to focus on the big picture.

Request a demo

TrialScope Disclose

Téléchargez votre livre blanc gratuit, « Compte à rebours du nouveau règlement européen sur les essais cliniques : à quoi s'attendre et comment se préparer »

22 Oct 2021

Des changements majeurs arrivent, impactant toutes les étapes des essais cliniques, y compris les essais nouveaux et en cours – êtes-vous prêt ? Sachez à quoi vous attendre et comment maintenir votre conformité en matière de divulgation lorsque le nouveau système d'information sur les essais cliniques (CTIS), créé par l'Agence européenne des médicaments (EMA), entrera en vigueur.

TrialScope Disclose

CTIS Best Practices Whitepaper

19 Oct 2021

Europe’s new Clinical Trial Information System (CTIS), created by the European Medicines Agency (EMA), is due to be implemented in January 2022. Find out what sponsors must do to ensure compliance with this far-reaching new regulatory requirement.

TrialScope Disclose

Clinical Trial Information System (CTIS)

14 Sep 2021

Created by the European Medicines Agency (EMA). Stakeholders will use CTIS to: Submit and approve clinical trial applications (CTAs), Submit trial reports, results and notifications, Communicate centrally with the Member States Concerned (MSC) in the clinical trial

TrialScope Disclose

TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process

25 Oct 2021

Dashboard automates disclosure, monitors compliance, consolidates global regulations and corporate transparency policies New York – October 26, 2021 – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, has launched TrialScope Atlas, a single, searchable dashboard that automates clinical trial disclosure and consolidates a concise set of relevant regulations.

TrialScope Disclose